-
Kenya's economy faces climate change risks: World Bank
-
World stocks mostly slide, consolidating Fed-fuelled gains
-
Crypto firm Tether bids for Juventus, is quickly rebuffed
-
UK's king shares 'good news' that cancer treatment will be reduced in 2026
-
Can Venezuela survive US targeting its oil tankers?
-
Salah admired from afar in his Egypt home village as club tensions swirl
-
World stocks retrench, consolidating Fed-fuelled gains
-
Iran frees child bride sentenced to death over husband's killing: activists
-
World stocks consolidate Fed-fuelled gains
-
France updates net-zero plan, with fossil fuel phaseout
-
Stocks rally in wake of Fed rate cut
-
EU agrees recycled plastic targets for cars
-
British porn star to be deported from Bali after small fine
-
British porn star fined, faces imminent Bali deportation
-
Spain opens doors to descendants of Franco-era exiles
-
Indonesia floods were 'extinction level' for rare orangutans
-
Thai teacher finds 'peace amidst chaos' painting bunker murals
-
Japan bear victim's watch shows last movements
-
South Korea exam chief quits over complaints of too-hard tests
-
French indie 'Clair Obscur' dominates Game Awards
-
South Korea exam chief resigns after tests dubbed too hard
-
Asian markets track Wall St record after Fed cut
-
Laughing about science more important than ever: Ig Nobel founder
-
Vaccines do not cause autism: WHO
-
Crypto mogul Do Kwon sentenced to 15 years for fraud: US media
-
'In her prime': Rare blooming of palm trees in Rio
-
Make your own Mickey Mouse clip - Disney embraces AI
-
OpenAI beefs up GPT models in AI race with Google
-
Dark, wet, choppy: Machado's secret sea escape from Venezuela
-
Cyclone causes blackout, flight chaos in Brazil's Sao Paulo
-
2024 Eurovision winner Nemo returns trophy over Israel's participation
-
US bringing seized tanker to port, as Venezuela war threats build
-
Make your own AI Mickey Mouse - Disney embraces new tech
-
Time magazine names 'Architects of AI' as Person of the Year
-
Floodworks on Athens 'oasis' a tough sell among locals
-
OpenAI, Disney to let fans create AI videos in landmark deal
-
German growth forecasts slashed, Merz under pressure
-
Thyssenkrupp pauses steel production at two sites citing Asian pressure
-
ECB proposes simplifying rules for banks
-
Stocks mixed as US rate cut offset by Fed outlook, Oracle earnings
-
Desert dunes beckon for Afghanistan's 4x4 fans
-
Breakout star: teenage B-girl on mission to show China is cool
-
Chocolate prices high before Christmas despite cocoa fall
-
Austria set to vote on headscarf ban in schools
-
Asian traders cheer US rate cut but gains tempered by outlook
-
AI's $400 bn problem: Are chips getting old too fast?
-
Oracle shares dive as revenue misses forecasts
-
US stocks rise, dollar retreats as Fed tone less hawkish than feared
-
Divided US Fed makes third straight rate cut, signals higher bar ahead
-
Machado to come out of hiding after missing Nobel ceremony
Disgraced surgeon on trial in Sweden over windpipe transplants
An Italian doctor who made headlines for pioneering windpipe surgery went on trial in Sweden on Wednesday, charged with assault for performing the experimental procedure.
Paolo Macchiarini won praise in 2011 after claiming to have performed the world's first synthetic trachea transplants using stem cells while he was a surgeon at Stockholm's Karolinska Institute.
The procedure was hailed as a breakthrough in regenerative medicine.
But allegations soon emerged that the risky procedure had been carried out on at least one person who had not been critically ill at the time of the operation.
The 63-year-old appeared in court in a blue suit Wednesday, where he listened to translated audio as prosecutors listed the charges of "aggravated assault" against three patients.
- 'Disregard for science' -
The Karolinska Institute has confirmed that the three individuals have since died, but did not directly link the deaths to the operations.
"Macchiarini has carried out the surgery with complete disregard for science and tried experience," prosecutor Karin Lundstrom-Kron told the court.
As prosecutors presented their case they referenced both external and internal reviews of the case, including one published in 2016 by physician Kjell Asplund, who argued that Macchiarini should never have been employed by Karolinska in the first place.
"It is clear that this method has not worked," prosecutor Jim Westerberg said, adding that Macchiarini had embellished the benefits of the procedure.
Macchiarini, who took notes without showing much emotion, has maintained the operations constituted treatments and not experiments, and denied being criminally responsible.
"He contends that he has performed health care, cured and helped," Macchiarini's lawyer Bjorn Hurtig told AFP during a recess.
The prosecution's presentation of evidence is expected to continue over several days so the defence will likely not be able to present its side until next week.
But Hurtig said they had "high hopes" they would be able to counter the prosecution's evidence.
"There are quite a lot of gaps in that evidence and there is a lot of evidence that we argue are favourable to our view of things," he said.
- Downplayed risks -
In 2013, the Karolinska hospital suspended all transplants and refused to extend Macchiarini's contract as a surgeon.
A year later, several surgeons at the hospital filed a complaint alleging that Macchiarini had downplayed the risks of the procedure.
Macchiarini carried out three surgeries at Karolinska University Hospital in 2011 and 2012, using an artificial windpipe made of plastic and coating it with the patient's own stem cells.
Together with his colleagues, he performed a total of eight such transplants between 2011 and 2014, the five others taking place in Russia.
An external review in 2015 found Macchiarini guilty of research misconduct, but despite sacking him, the Karolinska Institute repeatedly defended him until 2018, when it found him and several other researchers guilty.
The university's principal stepped down over the scandal, as well as a number of other people.
Medical journal The Lancet in 2018 retracted two papers authored by Macchiarini.
The trial, held in the Solna district court near the Karolinska Institute, is scheduled to take place over 13 days.
Ng.A.Adebayo--CPN